115 related articles for article (PubMed ID: 11432790)
1. Role of 67 kDa cell surface laminin binding protein of Leishmania donovani in pathogenesis.
Bandyopadhyay K; Karmakar S; Ghosh A; Das PK
J Biochem; 2001 Jul; 130(1):141-8. PubMed ID: 11432790
[TBL] [Abstract][Full Text] [Related]
2. Membrane orientation of laminin binding protein.
Bandyopadhyay K; Karmakar S; Biswas A; Das PK
Eur J Biochem; 2003 Sep; 270(18):3806-13. PubMed ID: 12950264
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody affinity purification of a 78 kDa membrane protein of Leishmania donovani of Indian origin and its role in host-parasite interaction.
Mukherjee M; Bhattacharyya A; Duttagupta S
J Biosci; 2002 Dec; 27(7):665-72. PubMed ID: 12571371
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a laminin-binding protein from the protozoan parasite Leishmania donovani that may mediate cell adhesion.
Ghosh A; Bandyopadhyay K; Kole L; Das PK
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):551-8. PubMed ID: 9895301
[TBL] [Abstract][Full Text] [Related]
5. High affinity binding between laminin and laminin binding protein of Leishmania is stimulated by zinc and may involve laminin zinc-finger like sequences.
Bandyopadhyay K; Karmakar S; Ghosh A; Das PK
Eur J Biochem; 2002 Mar; 269(6):1622-9. PubMed ID: 11895432
[TBL] [Abstract][Full Text] [Related]
6. Macrophage interactions with laminin: PMA selectively induces the adherence and spreading of mouse macrophages on a laminin substratum.
Mercurio AM; Shaw LM
J Cell Biol; 1988 Nov; 107(5):1873-80. PubMed ID: 2972733
[TBL] [Abstract][Full Text] [Related]
7. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
Mukherjee M; Bhattacharyya A; Duttagupta S
Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
[TBL] [Abstract][Full Text] [Related]
8. The major concanavalin A-binding surface glycoprotein of Leishmania donovani chagasi promastigotes is involved in attachment to human macrophages.
Wilson ME; Hardin KK
J Immunol; 1988 Jul; 141(1):265-72. PubMed ID: 3379307
[TBL] [Abstract][Full Text] [Related]
9. Heparin enhances the interaction of infective Leishmania donovani promastigotes with mouse peritoneal macrophages. A fluorescence flow cytometric analysis.
Butcher BA; Sklar LA; Seamer LC; Glew RH
J Immunol; 1992 May; 148(9):2879-86. PubMed ID: 1573275
[TBL] [Abstract][Full Text] [Related]
10. Virulence attenuation of a UDP-galactose/N-acetylglucosamine beta1,4 galactosyltransferase expressing Leishmania donovani promastigote.
Bhaumik SK; Singh M; Basu R; Bhaumik S; Roychoudhury K; Naskar K; Roy S; De T
Glycoconj J; 2008 Jul; 25(5):459-72. PubMed ID: 18197475
[TBL] [Abstract][Full Text] [Related]
11. Evidence of a laminin binding protein on the surface of Leishmania donovani.
Ghosh A; Kole L; Bandyopadhyay K; Sarkar K; Das PK
Biochem Biophys Res Commun; 1996 Sep; 226(1):101-6. PubMed ID: 8806598
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.
Jaffe CL; Rachamim N; Sarfstein R
J Immunol; 1990 Jan; 144(2):699-706. PubMed ID: 2295807
[TBL] [Abstract][Full Text] [Related]
13. Hepatic extracellular matrix in BALB/c mice infected with Leishmania donovani.
Leite VH; Croft SL
Int J Exp Pathol; 1996 Aug; 77(4):181-90. PubMed ID: 8943737
[TBL] [Abstract][Full Text] [Related]
14. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P
Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522
[TBL] [Abstract][Full Text] [Related]
15. Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa.
Das A; Jawed JJ; Das MC; Sandhu P; De UC; Dinda B; Akhter Y; Bhattacharjee S
Int J Antimicrob Agents; 2017 Oct; 50(4):512-522. PubMed ID: 28669838
[TBL] [Abstract][Full Text] [Related]
16. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.
Rachamim N; Jaffe CL
J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215
[TBL] [Abstract][Full Text] [Related]
17. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2.
Zhang WW; Matlashewski G
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8807-11. PubMed ID: 9238059
[TBL] [Abstract][Full Text] [Related]
18. Toll like receptor 2 and CC chemokine receptor 5 cluster in the lipid raft enhances the susceptibility of Leishmania donovani infection in macrophages.
Majumdar SB; Bhattacharya P; Bhattacharjee S; Majumder S; Banerjee S; Majumdar S
Indian J Exp Biol; 2014 Jan; 52(1):17-29. PubMed ID: 24617012
[TBL] [Abstract][Full Text] [Related]
19. Leishmania donovani Aurora kinase: A promising therapeutic target against visceral leishmaniasis.
Chhajer R; Bhattacharyya A; Didwania N; Shadab M; Das N; Palit P; Vaidya T; Ali N
Biochim Biophys Acta; 2016 Sep; 1860(9):1973-88. PubMed ID: 27288586
[TBL] [Abstract][Full Text] [Related]
20. Expression of a Leishmaniadonovani nucleotide sugar transporter in Leishmaniamajor enhances survival in visceral organs.
Zhang WW; Chan KF; Song Z; Matlashewski G
Exp Parasitol; 2011 Dec; 129(4):337-45. PubMed ID: 21978449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
